Ductal carcinoma in situ: state-of-the-art review
Ductal carcinoma in situ (DCIS) is a nonobligate precursor of invasive cancer, and its
detection, diagnosis, and management are controversial. DCIS incidence grew with the …
detection, diagnosis, and management are controversial. DCIS incidence grew with the …
Proteomics-Based identification of dysregulated proteins and biomarker discovery in invasive ductal carcinoma, the most common breast cancer subtype
Invasive ductal carcinoma (IDC) is the most common histological subtype of malignant
breast cancer (BC), and accounts for 70–80% of all invasive BCs. IDC demonstrates great …
breast cancer (BC), and accounts for 70–80% of all invasive BCs. IDC demonstrates great …
Clinical features and prognoses of patients with breast cancer who underwent surgery
Importance Breast cancer (BC) remains a pervasive malignant neoplasm worldwide, with
increasing incidence. However, there are a scarcity of studies examining the clinical …
increasing incidence. However, there are a scarcity of studies examining the clinical …
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Y Liu, T Yu - Journal of Cancer Research and Clinical Oncology, 2023 - Springer
Purpose The purpose of this study is to compare and analyze the clinicopathological
characteristics and prognosis of patients with invasive ductal carcinoma coexisting with …
characteristics and prognosis of patients with invasive ductal carcinoma coexisting with …
A multi-omics signature to predict the prognosis of invasive ductal carcinoma of the breast
Z Lin, Y He, C Qiu, Q Yu, H Huang, Y Zhang… - Computers in Biology …, 2022 - Elsevier
Background Precisely evaluating the prognosis of invasive ductal carcinoma (IDC) of the
breast is challenging as most prognostic signatures use single-omics data based on gene or …
breast is challenging as most prognostic signatures use single-omics data based on gene or …
[HTML][HTML] Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted …
X Guan, G Xu, A Shi, Y Zou, Y Zhan, Z Fan, Y Dong - Medicine, 2020 - journals.lww.com
This paper aimed to analyze the clinicopathological characteristics of invasive ductal
carcinoma with an invasive micropapillary carcinoma component (IDC+ IMPC), invasive …
carcinoma with an invasive micropapillary carcinoma component (IDC+ IMPC), invasive …
Bridging the Clinical-Computational Transparency Gap in Digital Pathology
Context.—Computational pathology combines clinical pathology with computational
analysis, aiming to enhance diagnostic capabilities and improve clinical productivity …
analysis, aiming to enhance diagnostic capabilities and improve clinical productivity …
Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta …
RAW Ploumen, CM de Mooij, S Gommers… - European …, 2023 - Springer
Objectives In approximately 45% of invasive breast cancer (IBC) patients treated with
neoadjuvant systemic therapy (NST), ductal carcinoma in situ (DCIS) is present. Recent …
neoadjuvant systemic therapy (NST), ductal carcinoma in situ (DCIS) is present. Recent …
Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy
H Zhou, J Yu, X Wang, K Shen, J Ye, X Chen - Scientific Reports, 2022 - nature.com
Ductal carcinoma in situ (DCIS) often upgrade to invasive breast cancer at surgery. The
current study aimed to identify factors associated with pathological underestimation and …
current study aimed to identify factors associated with pathological underestimation and …
[HTML][HTML] The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer
Y Bar, K Bar, D Feldman, J Ben-Dror, M Shahoha… - The Breast, 2024 - Elsevier
Background Early invasive ductal carcinoma (IDC) breast cancer often presents with a
coexisting ductal carcinoma in situ (DCIS) component, while about 5% of cases present with …
coexisting ductal carcinoma in situ (DCIS) component, while about 5% of cases present with …